# SECTION 5 - 510(k) Summary ELITech Clinical Systems TRIGLYCERIDES SL reagent

# Introduction

According to the requirements of 21 CFR 807.92, the following information provides sufficient detail to understand the basis for a determination of substantial equivalence.

The assigned 510(k) number is: _K102993_

Submitter Address Phone number Fax number

SEPPIM S.A.S.   
Zone Industrielle, 61500 SEES, FRANCE + 33 (0)2 33 81 21 00   
+ 33 (0)2 33 28 77 51

# Contact

Valérie GOURDON (Email: v.gourdon@elitechgroup.com)

Date of Preparation

September 30th, 2010

# Device name

# REAGENT:

Trade/proprietary Name: ELITech Clinical Systems TRIGLYCERIDES SL   
Common or Usual Name: Triglycerides, "TRIGLYCERIDES SL"   
Device Class Class I   
Classification name Triglyceride test system (Sec.862.1705)   
Product code CDT - Lipase Hydrolysis/Glycerol kinase enzyme, Triglycerides

# Predicate device

# ABX PENTRA TRIGLYCERIDES CP (K060854)

# Device description

The device for this submission is available as kit only. It consists of 1 reagent, "R".

Reagent R contains: Pipes buffer, $p$ -chlorophenol, ATP, Amino-4-antipyrine -AAP), Lipoprotein lipase (bacterial), Glycerol kinase (bacterial), Glycerol3-phosphate oxidase (microorganisms), Peroxidase (horseradish), Potassium ferrocyanide, Magnesium $( M g ^ { 2 + } )$ and Sodium azide.

# Intended Use

ELITech Clinical Systems TRIGLYCERIDES SL is intended for the quantitative in vitro diagnostic determination of triglycerides in human serum and plasma on ELITech Vital Scientific Selectra/Flexor analyzers. It is not intended for use in Point of Care settings

# Indication for use

ELITech Clinical Systems TRIGLYCERIDES SL is intended to measure triglycerides in human serum and plasma. Triglycerides measurements are used in the diagnosis and treatment of patients with diabetes mellitus, nephrosis, liver obstruction, other diseases involving lipid metabolism, or various endocrine disorders.

# Comparison to Predicate device

<table><tr><td colspan="1" rowspan="1">EY</td><td></td><td></td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">ELITech Clinical Systems DeviceTRIGLYCERIDES SL</td><td colspan="1" rowspan="1">Predicate device(ABX PENTRA TRIGLYCERIDES CP)</td></tr><tr><td colspan="1" rowspan="1">Intended use</td><td colspan="1" rowspan="1">For in vitro diagnostic use in the quan-titative determination of triglycerides inserum or plasma on ELITech VitalScientific Selectra/Flexor analyzers. Itis not intended for use in Point of Caresettings.</td><td colspan="1" rowspan="1">For in vitro diagnostic use in the quan-titative determination of triglycerides inserum or plasma.</td></tr><tr><td colspan="1" rowspan="1">Indication for Use</td><td colspan="1" rowspan="1">Intended to measure triglycerides inhuman serum and plasma. Triglyc-erides measurements are used in thediagnosis and treatment of patientswith diabetes mellitus, nephrosis, liverobstruction, other diseases involvinglipid metabolism, or various endocrinedisorders.</td><td colspan="1" rowspan="1">Intended to measure triglycerides inhuman serum and plasma. Triglyc-erides measurements are used in thediagnosis and treatment of patientswith diabetes mellitus, nephrosis, liverobstruction, other diseases involvinglipid metabolism, or various endocrinedisorders.</td></tr><tr><td colspan="1" rowspan="1">Assay protocol</td><td colspan="1" rowspan="1">Enzymatic colorimetric test</td><td colspan="1" rowspan="1">Enzymatic colorimetric test</td></tr><tr><td colspan="1" rowspan="1">Composition</td><td colspan="1" rowspan="1">Reagent:Pipes buffer            50 mmol/L ;Magnesium (Mg {)   14.8 mmol/L;p-chlorophenol         2.7 mmol/L;ATP                    3.15 mmol/L ;Potassium ferrocyanide 10 pmol/L;Amino-4-antipyrine     0.31 mmol/L;Lipoprotein lipase      ≥ 2000 U/L ;Glycerol kinase        ≥ 500 U/L ;Glycerol-3-phosphate oxidase ≥ 4000 U/L;Peroxidase             ≥ 500 U/L :Sodium azide          &lt; 0.1 %</td><td colspan="1" rowspan="1">Reagent:Pipes free acid         50 mmol/L;Sodium hydroxide     3.36 g/L;Triton X-100           1 ml/L;Magnesium salt        14.8 mmol/L;p-chlorophenol        2.7 mmol/L;ATP                    3.15 mmol/L;Sodium azide          7.99 mmol/L;Potassium ferrocyanide 10 pmol/L;4-aminoantipyrine     0.31 mmol/L;Lipoprotein lipase      ≥ 2000 U/L;Glycerokinase          ≥ 500 U/L;Peroxidase             ≥ 500 U/LGlycerol phosphate Oxidase ≥ 4000 U/L;</td></tr><tr><td colspan="1" rowspan="1">Appearance of reagent</td><td colspan="1" rowspan="1">Liquid form, ready to use</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Sample type</td><td colspan="1" rowspan="1">SerumPlasma in lithium heparin</td><td colspan="1" rowspan="1">SerumPlasma in lithium heparin</td></tr><tr><td colspan="1" rowspan="1">Reagent storage</td><td colspan="1" rowspan="1">Store at 2-8 C and protect from light.The reagent is stable until the expirydate stated on the label.</td><td colspan="1" rowspan="1">Reagents, in unopened cassette, arestable up to expiry date on the label ifstored at 2-8 C.</td></tr><tr><td colspan="1" rowspan="1">Expected values</td><td colspan="1" rowspan="1">Normal : &lt; 150 mg/dLBordeline high : 150-199 mg/dLHigh : 200-499 mg/dLVery high : ≥ 500 mg/dL</td><td colspan="1" rowspan="1">Normal: &lt; 150 mg/dlLow risk: 150 - 200 mg/dlHigh: 200 - 500 mg/dlExtremely high: &gt; 500 mg/dl</td></tr><tr><td colspan="1" rowspan="1">Instrument</td><td colspan="1" rowspan="1">Vital Scientific SELECTRA JUNIOR</td><td colspan="1" rowspan="1">ABX PENTRA 400</td></tr><tr><td colspan="1" rowspan="1">Measuring range</td><td colspan="1" rowspan="1">30 to 1000 mg/dL</td><td colspan="1" rowspan="1">3.1 to 1470 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Precision</td><td colspan="1" rowspan="1">Within runLevel 48 mg/dL CV=1.5%Level 142 mg/dL CV=1.0%Level 273 mg/dL CV=0.7%TotalLevel 48 mg/dL CV=3.9%</td><td colspan="1" rowspan="1">Within runLevel 126 mg/dLCV=2.52%Level214 mg/dLCV=0.82%Level60 mg/dL  CV=2.83%Level108 mg/dL CV=1.84%Level232 mg/dL CV=1.00%TotalLevel128 mg/dLCV=1.91%</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Level142 mg/dL CV=2.7%Level273 mg/dL CV=4.5%</td><td colspan="1" rowspan="1">Level216 mg/dL CV=1.70%Level132 mg/dLCV=1.57%Level243 mg/dLCV=1.37%</td></tr><tr><td colspan="1" rowspan="1">Method comparison</td><td colspan="1" rowspan="1">y=1.040x + 0.339 mg/dl$2{}= 0.998range: 22 to 936 mg/dL</td><td colspan="1" rowspan="1">y=0.99x + 0.20 mg/dLr^2= 0.9994range: 3.1 to 1434.1 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Limitations</td><td colspan="1" rowspan="1">Unconjugated bilirubin:No significant interference up to 15mg/dL .Conjugated bilirubin:No significant interference up to 5.9mg/dLHemoglobin:No significant interference up to 250mg/dL.Uric acid:No significant interference up to 23.6mg/dLAscorbic acid:No significant interference up to 2.0mg/dL. Concentrations abovethetherapeutic levels will interfere andcause erroneous results.Methyl-dopa:No significant interference up to 1.0mg/dL</td><td colspan="1" rowspan="1">Hemoglobin: No significant influenceis observed up to 500 mg/dL.Total bilirubin: No significant influ-ence is observed up to 22.5 mg/dL.Direct bilirubin: No significant influ-ence is observed up to 22.5 mg/dL.</td></tr><tr><td colspan="1" rowspan="1">Calibration Frequency</td><td colspan="1" rowspan="1">14 days</td><td colspan="1" rowspan="1">14 days</td></tr><tr><td colspan="1" rowspan="1">On board stability</td><td colspan="1" rowspan="1">refrigerated area : 28 days</td><td colspan="1" rowspan="1">refrigerated area: 48 days</td></tr><tr><td colspan="1" rowspan="1">Calibrator</td><td colspan="1" rowspan="1">Recommended calibration material(not included):ELITech Clinical Systems ELICAL 2</td><td colspan="1" rowspan="1">Recommended calibration material(not included):ABX Pentra Multical</td></tr><tr><td colspan="1" rowspan="1">Controls</td><td colspan="1" rowspan="1">Recommended quality control material(not included):ELITech Clinical Systems ELITROL I(Normal control)ELITech Clinical Systems ELITROL II(Pathologic control)</td><td colspan="1" rowspan="1">Recommended quality control material(not included):ABX Pentra N Control(Normal control)ABX Pentra P Control (Pathologiccontrol)</td></tr></table>

# Device name

# REAGENT:

Trade/proprietary Name: ELITech Clinical Systems CHOLESTEROL SL

Common or Usual Name: Cholesterol (total), "CHOLEsTEROL SL" Device Class Class I Classification name Cholesterol (total) test system (Sec.862.1175) Product code CHH - Enzymatic Esterase-Oxidase, Cholesterol

# Predicate device

<table><tr><td>Device description</td><td>The device for this submission is available as kit only. It consists of 1 reagent, &quot;R&quot;. Reagent R contains: Pipes buffer, 4-Aminoantipyrine (4-AAP), Cholesterol esterase (CHE bacterial), Cholesterol oxidase (CHO microorganims), Per-</td></tr><tr><td>Intended Use</td><td>ELITech Clinical Systems CHOLESTEROL SL is intended for the quantita- - tive in vitro diagnostic determination of cholesterol in human serum and plasma on ELITech Vital Scientific Selectra/Flexor analyzers. It is not in- tended for use in Point of Care settings.</td></tr><tr><td>Indication for use</td><td>ELITech Clinical Systems CHOLESTEROL SL is intended to measure cholesterol in human serum and plasma. Cholesterol measurements are used in the diagnosis and treatment of disorders involving excess choles- terol in the blood and lipid and lipoprotein metabolism disorders.</td></tr></table>

# Comparison to Predicate device

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">ELITech Clinical Systems DeviceCHOLESTEROL SL</td><td colspan="1" rowspan="1">Predicate device(ABX PENTRA CHOLESTEROL CP)</td></tr><tr><td colspan="1" rowspan="1">Intended use</td><td colspan="1" rowspan="1">For in vitro diagnostic use in the quan-titative determination of cholesterol inserum or plasma on ELITech VitalScientific Selectra/Flexor analyzers. Itis not intended for use in Point of Caresettings.</td><td colspan="1" rowspan="1">For in vitro diagnostic use in the quan-titative determination of cholesterol inserum or plasma.</td></tr><tr><td colspan="1" rowspan="1">Indication for Use</td><td colspan="1" rowspan="1">Cholesterol measurements are usedin the diagnosis and treatment of dis-orders involving excess cholesterol inthe blood and lipid and lipoproteinmetabolism disorders.</td><td colspan="1" rowspan="1">Cholesterol measurements are usedin the diagnosis and treatment of dis-orders involving excess cholesterol inthe blood and lipid and lipoproteinmetabolism disorders.</td></tr><tr><td colspan="1" rowspan="1">Assay protocol</td><td colspan="1" rowspan="1">Enzymatic colorimetric method usingcholesterol  esterase/   cholesteroloxidase coupled with peroxidase(Trinder method).</td><td colspan="1" rowspan="1">Enzymatic colorimetric method usingcholesterol esterase/ cholesterol oxi-dase coupled with peroxidase (Trindermethod).</td></tr><tr><td colspan="1" rowspan="1">Composition</td><td colspan="1" rowspan="1">Reagent:Pipes buffer             50 mmol/L ;Phenol                  24 mmol/L;Sodium cholate          5 mmol/L;4-Aminoantipyrine      0.5 mmol/L ;Cholesterol esterase     ≥ 180 U/L ;Cholesterol oxidase     ≥ 200 U/L ;Peroxidase            ≥ 1 000 U/L ;Sodium azide                &lt;1g/L</td><td colspan="1" rowspan="1">Reagent:Good's buffer            50 mmol/L;Phenol                   5 mmol/L;4-Aminoantipyrine      0.3 mmol/L;Cholesterol esterase    ≥ 200 U/L ;Cholesterol oxidase       ≥ 50 U/L ;Peroxidase             ≥ 3 000 U/L ;Sodium azide               0.95 g/L</td></tr><tr><td colspan="1" rowspan="1">Appearance of re-agent</td><td colspan="1" rowspan="1">Liquid form, ready to use</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Sample type</td><td colspan="1" rowspan="1">SerumPlasma in lithium heparin</td><td colspan="1" rowspan="1">SerumPlasma in lithium heparin</td></tr><tr><td colspan="1" rowspan="1">Reagent storage</td><td colspan="1" rowspan="1">Store at 2-8°C and protect from light.The reagent is stable until the expirydate stated on the label.</td><td colspan="1" rowspan="1">Reagents, in unopened cassette, arestable up to expiry date on the label ifstored at 2-8° and contamination isavoided.</td></tr><tr><td colspan="1" rowspan="1">Expected values</td><td colspan="1" rowspan="1">Desirable: &lt; 200 mg/dLBordeline high: 200-239 mg/dLHigh: ≥ 240 mg/dL</td><td colspan="1" rowspan="1">Desirable: ≤ 200 mg/dlBorderline high risk: 200-239 mg/dLHigh risk: &gt; 240 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Instrument</td><td colspan="1" rowspan="1">Vital Scientific SELECTRA JUNIOR</td><td colspan="1" rowspan="1">ABX PENTRA 400</td></tr><tr><td colspan="1" rowspan="1">Measuring range</td><td colspan="1" rowspan="1">20 to 600 mg/dL</td><td colspan="1" rowspan="1">2.55 to 580 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Precision</td><td colspan="1" rowspan="1">Within runLevel 116 mg/dLCV=2.4%Level 190 mg/dLCV=1.9%Level 298 mg/dLCV=1.7%TotalLevel|116 mg/dLCV=2.6%Level190 mg/dLCV=2.7%Level 298 mg/dLCV=2.7%</td><td colspan="1" rowspan="1">Within runLevel 113 mg/dLCV=0.82%Level 186 mg/dLCV=0.74%Level117 mg/dLCV=1.21%Level191 mg/dLCV=0.53%Level 389 mg/dLCV=0.62%TotalLevel109 mg/dLCV=2.96%Level183 mg/dLCV=2.34%Level170 mg/dLCV=2.80%Level 250 mg/dLCV=3.01%</td></tr><tr><td colspan="1" rowspan="1">Method comparison</td><td colspan="1" rowspan="1">y=1.006 x - 1.734 mg/dL$^2= 0.999range: 20 to 579 mg/dL</td><td colspan="1" rowspan="1">y=0.95x + 1.90 mg/dL$^2{}0.9943range: 2.55 to 583.26 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Cholesterol ReferenceLaboratory Network(CRMLN) certification</td><td colspan="1" rowspan="1">Certified</td><td colspan="1" rowspan="1">Certified</td></tr><tr><td colspan="1" rowspan="1">Limitations</td><td colspan="1" rowspan="1">Unconjugated bilirubin: No signifi-cant interference up to 6.0 mg/dL.Conjugated bilirubin: No significantinterference up to 5.9 mg/dL.Hemoglobin: No significant interfer-ence up to 250 mg/dL.Turbidity: No significant interferenceup to 614 mg/dL triglyceride equiva-lent.Ascorbic acid: No significant interfer-ence up to 2.0 mg/dL. Concentrationsabove the therapeutic levels will inter-fere and cause erroneous results.Methyl-dopa: No significant interfer-ence up to 0.8 mg/dL. Concentrationsabove the therapeutic levels will inter-fere and cause erroneous results.Uric acid: No significant interferenceup to 23.4 mg/dL.</td><td colspan="1" rowspan="1">Hemoglobin: No significant influenceis observed up to 336 mg/dL.Total bilirubin: No significant influ-ence is observed up to 20.5 mg/dL.Direct bilirubin: No significant influ-ence is observed up to 6.8 mg/dL.Triglycerides: No significant influenceis observed up to 612.5 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Calibration Frequency</td><td colspan="1" rowspan="1">28 days</td><td colspan="1" rowspan="1">8 days</td></tr><tr><td colspan="1" rowspan="1">On board stability</td><td colspan="1" rowspan="1">refrigerated area : 28 days</td><td colspan="1" rowspan="1">refrigerated area: 48 days</td></tr><tr><td colspan="1" rowspan="1">Calibrator</td><td colspan="1" rowspan="1">Recommended calibration material(not included):ELITech Clinical Systems ELICAL 2</td><td colspan="1" rowspan="1">Recommended calibration material(not included):ABX Pentra Multical</td></tr><tr><td colspan="1" rowspan="1">Controls</td><td colspan="1" rowspan="1">Recommended quality control material(not included):ELITech Clinical Systems ELITROL I(Normal control)ELITech Clinical Systems ELITROL II(Pathologic control)</td><td colspan="1" rowspan="1">Recommended quality control material(not included):ABX Pentra N Control(Normal control)ABX Pentra P Control (Pathologiccontrol</td></tr></table>

# Device name

# CALIBRATOR :

ade/proprietary Name: ELITech Clinical Systems ELICAL 2

Common or Usual Name: Calibrator, multi-analyte mixture, "ELICAL 2 Device Class Class II Classification name Calibrator (21 CFR 862.1150) Product code JIX- Calibrator, multi-analyte mixture

# Predicate device

Roche Diagnostics Calibrator for Automated Systems (C.f.a.s) (K033501)

# Device description

ELITech Clinical Systems ELICAL 2 is a lyophilized calibrator based or human serum containing constituents to ensure optimal calibration.

ELICAL 2 is prepared exclusively from the blood of donors tested individually and found to be negative for HbsAg and to antibodies to HCV and HIV according to FDA-approved methods or methods in compliance with the European Directive 98/79/EC, Annex II, List A.

# Intended Use

ELITech Clinical Systems ELICAL 2 is a multi-parametric calibrator for in vitro diagnostic use in the calibration of quantitative ELITech Clinical Systems methods on the ELITech Vital Scientific Selectra/Flexor Analyzers.

# Comparison to Predicate device

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">ELITech Clinical Systems DeviceELICAL 2</td><td colspan="1" rowspan="1">Predicate device(Roche Calibrator f.a.s.)</td></tr><tr><td colspan="1" rowspan="1">Intended use</td><td colspan="1" rowspan="1">ELITech Clinical Systems ELICAL 2is a multi-parametric calibrator for invitro diagnostic use in the calibra-tion of quantitative ELITech ClinicalSystems methods on the ELITechVital Scientific Selectra/Flexor Ana-lyzers.</td><td colspan="1" rowspan="1">For in vitro diagnostic use in thecalibration of quantitative Rochemethods on Roche clinical chemis-try analysers as specified in thevalue sheets.</td></tr><tr><td colspan="1" rowspan="1">Format</td><td colspan="1" rowspan="1">Lyophilized calibrator based onhuman serum with constituentsadded as required to obtain desiredcomponents levels</td><td colspan="1" rowspan="1">Lyophilized calibrator based onhuman serum with constituentsadded as required to obtain desiredcomponents levels</td></tr><tr><td colspan="1" rowspan="1">Level</td><td colspan="1" rowspan="1">Single level</td><td colspan="1" rowspan="1">Single level</td></tr><tr><td colspan="1" rowspan="1">Handling</td><td colspan="1" rowspan="1">Carefully open the vial, avoiding theloss of lyophilate, and pipette inexactly 3 mL of distilled/deionizedwater. Carefully close the vial anddissolve the contents completely byoccasional gentle swirling within 30minutes avoiding the formation offoam.</td><td colspan="1" rowspan="1">Carefully open one bottle, avoidingthe loss of lyophilate, and pipette inexactly 3 mL of distilled/deionizedwater. Carefully close the bottle anddissolve the contents completely byoccasional gentle swirling within 30minutes. Avoid the formation offoam.</td></tr><tr><td colspan="1" rowspan="1">Traceability</td><td colspan="1" rowspan="1">Traceability information is given inthe value sheet included in the box.</td><td colspan="1" rowspan="1">Traceability of the target value isgiven in the respective instructionfor use of the system reagents.</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">ELITech Clinical Systems Device(ELICAL 2)</td><td colspan="1" rowspan="1">Predicate device(Roche Calibrator f.a.s.)</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Stability</td><td colspan="1" rowspan="1">Lyophilized:To store at 2-8°C and protectedfrom light until the expiry dateAfter reconstitution, the stabilitiesare :- 8 hours between 15-25 °C.- 2 days between 2-8 °C.- 4 weeks between -25 and -15 °C(when frozen once)</td><td colspan="1" rowspan="1">Lyophilized:Stable at 2-8°C up to expirationdate.After reconstitution, the stabilities*are :- 8 hours at 15-25 °C.- 2 days at 2-8 °C.- 4 weeks at (-25)-(-15) °C (whenfrozen once)*Exception for bilirubin total &amp; directas noted in package insert</td></tr></table>

# Device names

CONTROLS:   
Trade/proprietary Name:   
Common or Usual Name:   
Device Class   
Classification name

Product code

ELITech Clinical Systems ELITROL I and ELITROL II   
Multi-analyte controls — all kinds, "ELITROL I" "ELITROL II"   
Class I   
Quality control material (assayed and unassayed). (21 CFR   
862.1660)   
JJY Multi-analyte controls - all kinds

<table><tr><td>Predicate device</td><td>Roche Diagnostics Precinorm U (K041227) Roche Diagnostics Precipath U (K041227)</td></tr><tr><td>Device description</td><td>ELITech Clinical Systems ELITROL I and ELITROL II are two level quality control products consisting of lyophilized human serum containing constitu- ents at desired levels. Elitrol I and Elitrol Il are prepared exclusively from the blood of donors tested individually and found to be negative for HbsAg and to antibodies to HCV and HIV according to FDA-approved methods or methods in compliance with the European Directive 98/79/EC, Annex II, List A.</td></tr><tr><td>Intended Use</td><td>ELITech Clinical Systems ELITROL I &amp; ELITROL II are multiparametric control sera for use in quality control of ELITech Clinical Systems methods on ELITech Vital Scientific Selectra/Flexor Analyzers.</td></tr></table>

# Comparison to Predicate device

Page 5.7 of 5.8 pages   

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">ELITech Clinical Systems DeviceELITROL I/ELITROL II</td><td colspan="1" rowspan="1">Predicate DeviceRoche Precinorm U / Precipath U</td></tr><tr><td colspan="1" rowspan="1">Intended use</td><td colspan="1" rowspan="1">ELITech Clinical Systems ELITROLI &amp; ELITROL II are multiparametriccontrol sera for use in quality con-trol of ELITech Clinical Systemsmethods on ELITech Vital Scientific</td><td colspan="1" rowspan="1">For in vitro diagnostic use in qualitycontrol by monitoring accuracy andprecision for the quantitative meth-ods as specified in the value sheet</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Selectra/Flexor Analyzers.</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Format</td><td colspan="1" rowspan="1">Lyophilized human sera with con-stituents added as required to ob-tain desired components levels</td><td colspan="1" rowspan="1">Lyophilized human sera with con-stituents added as required to ob-tain desired components levels</td></tr><tr><td colspan="1" rowspan="1">Levels</td><td colspan="1" rowspan="1">Two levels</td><td colspan="1" rowspan="1">Two levels</td></tr><tr><td colspan="1" rowspan="1">Handling</td><td colspan="1" rowspan="1">Carefully open the vial, avoiding theloss of lyophilate, and pipette inexactly 5 mL of distilled/deionizedwater. Carefully close the vial anddissolve the contents completely byoccasional gentle swirling within 30minutes avoiding the formation offoam.</td><td colspan="1" rowspan="1">Carefully open the bottle, avoidingthe loss of lyophilate, and pipette inexactly 5 mL of distilled/deionizedwater. Carefully close the bottle anddissolve the contents completely byoccasional gentle swirling within 30minutes. Avoid the formation offoam.</td></tr><tr><td colspan="1" rowspan="1">Stability</td><td colspan="1" rowspan="1">Lyophilized:To store at 2-8°C and protectedfrom light until the expiry dateAfter reconstitution, the stabilitiesare :- 12 hours between 15-25 °C.- 5 days between 2-8 °C.- 4 weeks between -25 and -15 (when frozen once)</td><td colspan="1" rowspan="1">Lyophilized:Stable at 2-8°C up to expirationdate.After reconstitution, the stabilities*are :- 12 hours at 15-25 C.- 5 days at 2-8 C.- 4 weeks at (-25)-(-15) °C (whenfrozen once)*Exception for bilirubin total &amp; directas noted in package insert</td></tr></table>

# Conclusion

The performance data and other information demonstrate that the safety and effectiveness of these devices versus their respective predicate devices are not compromised, and that they met all acceptance criteria, demonstratin that the devices e substantialy equivalent t ther respective predicate devices.

SEPPIM S.A.S.   
Elitech Group Epoch Biosciences   
c/o Ms. Debra Hutson   
Director, Quality Assurance/Regulatory Affairs 21720 23rd Drive, S.E., Suite 150   
Bothell, Washington 98021

Re: k102993 Trade Name: ELITech Clinical Systems Cholesterol SL, ELITech Clinical Systems Triglycerides SL, ELITech Clinical Systems Elical 2, ELITech Clinical Systems Elitrol I and II Regulation Number: 21 CFR $\ S 8 6 2 . 1 1 7 5$ EY Regulation Name: Cholesterol Test System. Regulatory Class: Class I, meets the limitations to exemptions 21 CFR 862.9 (c)(4) Product Codes: CHH, CDT, JIX, JJY Dated: April 29, 2011 Received: May 03, 2011

Dear Ms. Hutson:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2 -

If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and   
809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-   
5450. Also, please note the regulation entitled, "Misbranding by reference to premarket   
notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under   
the MDR regulation (21 CFR Part 803), please go to   
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office   
of Surveillance and Biometrics/Division of Postmarket Surveillance.: You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address   
http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

aC.

Couthey Harper, Ph.D.   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and Radiological Health

# Indications for Use Form

510(k) Number (if known): _K102993

Device Name: ELITech Clinical Systems TRIGLYCERIDES SL

Indications for Use:

ELITech Clinical Systems TRIGLYCERIDES SL is intended for the quantitative in vitro diagnostic determination of triglycerides in human serum and plasma on ELTech Vital Scientific Selectra/Flexor analyzers. It is not intended for use in Point Care settings

Triglycerides measurements are used in the diagnosis and treatment of patients with diabetes mellitus, nephrosis, liver obstruction, other diseases involving lipid metabolism, or various endocrine disorders.

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/203748141d8009d9f3e1487e7793e5c87e0d14bbf13149a31ffa6bf5efb7b79a.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

510(k) K102991

# Indications for Use Form

510(k) Number (if known): __K102993.

Device Name: ELITech Clinical Systems CHOLESTEROL SL.

Indications for Use:

ELITech Clinical Systems CHOLESTEROL SL is intended for the quantitative in vitro diagnostic determination of cholesterol in human serum and plasma on ELITech Vital Scientific Selectra/Flexor analyzers. It is not intended for use in Point of Care settings.

Cholesterol measurements are used in the diagnosis and treatment of disorders involving excess cholesterol in the blood and lipid and lipoprotein metabolism disorders.

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/dbf13bf6d5f73e6cb89a42f12af364e4e7ea9e2d3f7451b8f633a1a86820a68f.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

510(k) k102993

# Indications for Use Form

510(k) Number (if known): __K102993

Device Name: ELITech Clinical Systems ELICAL 2

Indications for Use:

ELITech Clinical Systems ELICAL 2 is a multi-parametric calibrator for in vitro diagnostic use in the calibration of quantitative ELITech Clinical Systems methods on the ELITech Vital Scientific Selectra/Flexor Analyzers.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/5846fd53bf5b388abc0554bc2abed70bbbfab70abe6c3d956ee51ef6acfedfcb.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

# Indications for Use Form

510(k) Number (if known): _K 102993

Device Name: ELITROL I and ELITROL I

Indications for Use:

ELITech Clinical Systems ELITROL I & ELITROL II are multiparametric control sera for use in quality control of ELITech Clinical Systems methods on ELITech Vital Scientific Selectra/Flexor Analyzers.

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/579abb00c616f693783bc954a5bc011ecf3e14f205d580cefe09ff67a46f6364.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

510(k) (102993